The new GSK logo acts as a sign that “always points the way ahead ... “Today, GSK is a different company from the GlaxoSmithKline that launched in 2000, and the global context around it has shifted ...

GSK lowered its 2024 vaccine sales forecast for the second time this year on Wednesday, hit by weak demand for its ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

British pharmaceutical company GSK reported on Wednesday that its third-quarter profit before tax dropped to £64 million ($83 ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Barclays lowered the firm’s price target on GSK (GSK) to 1,450 GBp from 1,550 GBp and keeps an Equal Weight rating on the shares.

British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster COVID-19 ...

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

GSK PLC GSK shares inched up 0.07% to £13.81 Friday, on what proved to be an all-around poor trading session for the stock ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

GSK PLC GSK shares inched up 0.69% to £13.80 Thursday, on what proved to be an all-around poor trading session for the stock ...